Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares Repurchased
Ratios

Cross Country Healthcare (CCRN) Non-Current Receivables (2021 - 2025)

Cross Country Healthcare's Non-Current Receivables history spans 9 years, with the latest figure at $14.9 million for Q4 2025.

  • For Q4 2025, Non-Current Receivables fell 29.0% year-over-year to $14.9 million; the TTM value through Dec 2025 reached $14.9 million, down 29.0%, while the annual FY2025 figure was $14.9 million, 29.0% down from the prior year.
  • Non-Current Receivables reached $14.9 million in Q4 2025 per CCRN's latest filing, roughly flat from $14.9 million in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $25.7 million in Q4 2023 to a low of $14.0 million in Q4 2021.
  • Average Non-Current Receivables over 5 years is $20.4 million, with a median of $21.8 million recorded in 2024.
  • Peak YoY movement for Non-Current Receivables: skyrocketed 64.72% in 2022, then tumbled 31.72% in 2025.
  • A 5-year view of Non-Current Receivables shows it stood at $14.0 million in 2021, then soared by 64.72% to $23.1 million in 2022, then increased by 11.52% to $25.7 million in 2023, then dropped by 18.61% to $20.9 million in 2024, then dropped by 29.0% to $14.9 million in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Non-Current Receivables are $14.9 million (Q4 2025), $14.9 million (Q3 2025), and $16.2 million (Q2 2025).